Back

Prospects of target series clinical trials.

29 August 2022 (13:20 - 13:30)
Organised by:
Congress Presentation Part of: 5-year outcomes of target all comers randomised trial & prospects of target series clinical trials Interventional Cardiology Open Access ESC Congress 2022

About the speaker

Photo
Associate Professor Giuseppe Tarantini

University of Padua, Padova (Italy)

7 More presentations in this session

Presentation thumbnail
Opening & target AC project introduction.
Professor A. Baumbach (London, GB)
Slides Video
Presentation thumbnail
5-year outcomes of target all comers randomised trial.
Doctor A. Lansky (New Haven, US)
Slides Video
Presentation thumbnail
Group discussion.
Doctor L. Janssens (Bonheiden, BE) Professor B. Xu (Beijing, CN) Doctor L. Holmvang (Copenhagen, DK) Doctor T. Johnson (Bristol, GB)
Video
Presentation thumbnail
TARGET AC sub-group analysis on diabetics and ACS patients.
Professor N. van Royen (Nijmegen, NL)
Slides Video
Presentation thumbnail
Group discussion.
Doctor L. Holmvang (Copenhagen, DK) Professor B. Xu (Beijing, CN) Doctor T. Johnson (Bristol, GB) Doctor L. Janssens (Bonheiden, BE)
Video

Access the full session

Session thumbnail
5-year outcomes of target all comers randomised trial & prospects of target series clinical trials
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 13:20 CET
You may be interested in
thumbnail
Congress Presentation
Breaking through: CETP inhibitors and the future of lipid therapy
thumbnail
Congress Presentation
Redrawing the map: why we must cross boundaries in lipid management
thumbnail
Congress Presentation
Key takeaways & practical guidance

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources